Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Hampton Court Allergy Screening A Success, UK
The National Pharmacy Association and Allergy UK provided free allergy screening to the public at Hampton Court Palace Flower Show from 7-12 July. Over 7,000 members of the public picked up information on community pharmacy allergy screening or asked for advice and 75 allergy screenings were carried out.
generic viagra online
Eliminating Polio Requires Global, Coordinated Effort -- Health Affairs Article Highlights Potential Risks, Rewards Of Worldwide Eradication
Eliminating polio everywhere will require global cooperation on several fronts, including lowering the cost for poor countries to vaccinate with inactivated polio vaccine (IPV), says a leading global health researcher in the July/August Health Affairs thematic issue on global health.
News of the day
Johns Hopkins Faculty Members Awarded 2009 White House Early Career Awards
Pablo A. Celnik, M.D., an assistant professor of physical medicine and rehabilitation and neurology at the Johns Hopkins University School of Medicine, and Thao (Vicky) Nguyen, 32, assistant professor of mechanical engineering in the Whiting School of Engineering at The Johns Hopkins University, are among the 100 winners of this year"s Presidential Early Career Award for Scientists and Engineers (PECASE).
Nutrition

Critical Health (Booth C3) Launches Innovative Diabetic Retinopathy Progression Biomarker Software Solution, RetmarkerDR, In The European Market

Critical Health will be launching RetmarkerDR, an innovative Diabetic Retinopathy (DR) progression biomarker software in the European market at the Euretina exhibition (Booth C3; 14th to 17th May; Acropolis Centre; Nice; France). Critical Health is a leading provider of innovative products that help prevent the loss of vision, mobility and cognitive skills in an ageing population. Also at the 9th Euretina Congress, leading researchers from Critical Health"s partner AIBILI (Association for Biomedical Research and Innovation in Light and Image), will be presenting new research results that support this breakthrough in predicting Diabetic Retinopathy progression. On the 14th of May, at Session 1 - Imaging to Monitor Progression, Professor Cunha-Vaz, AIBILI, will be presenting "The importance of monitoring progression in the early stages of retinal disease", to be followed by Professor Bernardes, Director of the Center of New Technologies for Medicine - AIBILI, regarding "Retmarker. Identifying progression on fundus images". The RetmarkerDR software solution is a breakthrough in predicting Diabetic Retinopathy progression from a Nonproliferative stage to Clinically Significant Macular Edema (CSME), a sight-threatening stage. The solution is based on the latest research on Microaneurysm Turnover, the new and most reliable biomarker of Diabetic Retinopathy progression. "This solution will become a critical tool to support ophthalmologists worldwide in the search for optimal management of diabetic retinopathy progression", said Ricardo Cunha-Vaz, Critical Health"s CEO. "RetmarkerDR helps to deliver quality care and to reduce total healthcare spending by increasing the healthcare provider"s productivity and reliability in the management of Diabetic Retinopathy and other retinal diseases". The RetmarkerDR solution underlying approach is supported by recent leading edge research being presented by AIBILI at the most important scientific forums. Recently, two scientific papers supporting the RetmarkerDR technology were accepted for publication in the Ophthalmologica magazine and posters were presented at ARVO, in Fort Lauderdale, Florida, USA. The main conclusions of these studies are: Microaneurysm Turnover (more than just MA count) is a key indicator for the progression of Diabetic Retinopathy. RetmarkerDR is a reliable software tool which can be used to capture the MA turnover in the initial stages of DR. For more information please visits http://www.retmarker.com Critical Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009